How can we develop a cost-effective quality cervical screening programme?

British Journal of General Practice

Volumn 52, Issue 479, 2002, Pages 485-490

  Wilson, Sue ^a   Lester, Helen ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Cervical intraepithelial neoplasia; Cervical screening programme; Cost effectiveness; Screening interval

Indexed keywords

CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE QUALITY; HIGH RISK POPULATION; HUMAN; PAPANICOLAOU TEST; REVIEW; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; AGE FACTORS; COST-BENEFIT ANALYSIS; FEMALE; GREAT BRITAIN; HUMANS; MASS SCREENING; MIDDLE AGED; PROGRAM DEVELOPMENT; QUALITY ASSURANCE, HEALTH CARE; UTERINE CERVICAL NEOPLASMS;

EID: 0036265404     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Effect of screening on incidence and mortality from cancer of the cervix: Evaluation based on routinely collected statistics
2. The impact of screening on the incidence of cervical cancer in England and Wales
3. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer
4. Cervical screening programme, England: 1999-2000
5. Public understanding of medical screening
6. Cervical cancer screening
7. Current approaches to cervical screening
8. Cervical cancer prevention: Towards cost-effective screening
9. Assessing the effectiveness of community screening programmes
10. Use of routine data to monitor and evaluate cervical screening
11. Natural history of cervical intra-epithelial neoplasia: A critical review
12. Progressive potential of mild cervical atypia: Prospective cytological, colposcopic and virological study
13. The natural history of dysplasia of the uterine cervix
14. A follow-up study of patients with cervical dysplasia
15. Screening strategies for cervical cancer and cervical intraepithelial neoplasia
16. Natural history of cervical human papillomavirus infection in young women: A longitudinal cohort study
17. Missed opportunities for cervical cancer screening of HMO members developing invasive cervical cancer
18. Achievable laboratory standards: A review of cytology of 99 women with cervical cancer
19. Costs and benefits of cervical screening
20. Women's concerns about abnormal Papanicolaou results
21. Psychosexual trauma of an abnormal cervical smear
22. The current status of the Papanicolaou smear
23. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytological abnormalities: A systematic review
24. Meta-analysis of Pap test accuracy
25. Determinants of cancer screening frequency: The example of screening for cervical cancer
26. Does a zero error standard exist for the Papanicolaou smear? A pathologists perspective
27. False-negative results in screening programmes: Systematic review of impact and implications
28. Report on a Workshop of the UICC Project on Evaluation of Screening for Cancer
29. A national screening programme: The answer to cancer of the cervix
30. Optimal use of Pap Smear screening for cervical cancer
31. Cancer screening
32. The positive predictive value of cervical smears in previously screened postmenopausal women: The heart and estrogen/progestin replacement study (HERS)
33. Rationale for stopping cervical screening in women over 50
34. Withdrawing low risk women from cervical screening programmes: Mathematical modelling study
35. Relation between the incidence of invasive cervical cancer and the screening interval: Is a five year interval too long?
36. Costs and benefits of cervical screening II. Is it worth reducing the screening interval from five to three years?
37. Economic aspects of cervical screening
38. An evaluation of screening policies for cervical cancer in England and Wales using a computer simulation model
39. Risk targeting in cervical screening: A new look at an old problem
40. Ages and frequencies for cervical cancer screening
41. Cervical samplers: Most important variable is probably the operator's skill
42. Does mild atypia on a cervical smear warrant further investigation?
43. Does feedback improve the quality of cervical smears? A randomised controlled trial
44. Anxiety caused by abnormal results of cervical smear test: A controlled trial
45. Is default from colposcopy a problem, and if so, what can we do? A systematic review of the literature
46. Efficacy of cervical smear collection devices: A systematic review and meta-analysis
47. Relation between sampling device and detection of abnormality in cervical smears: A meta-analysis of randomised and quasi-randomised studies
48. Intra-observer variability in the quality assessment of cervical smears
49. Interobserver variation in histo-pathological grading of cervical dysplasia
50. Waiting times for cancer patients in England after general practitioner referrals: Retrospective national study
51. Invitation to attend a health check in a general practice setting: Comparison of attenders and non-attenders
52. An economic view of high compliance as a screening object
53. Compliance in screening programme: High compliance essential in cervical screening programme
54. Why is there no progress against cervical cancer